Trademark protection for pharmaceuticals: Current developments and landmark decisions

Discover in the article by Dr. Magnus Hirsch in the Pharmaceutical Trade Marks Group (PTMG) an innovative decision by the Hanseatic Higher Regional Court of Hamburg. This concerns the use of trademarks for medicinal products without a specific marketing authorization and the associated preservation of trademark rights. The decision provides important clarifications and insights into the legal landscape. It clarifies that a marketing authorization as a medicinal product is not a mandatory requirement for the use of the trademark category “medicinal product” for the protection of trademark rights. It also sheds light on the likelihood of confusion between the H 15 marks and similar signs of the defendant. The article provides a fascinating insight into the dynamics of trademark protection in the field of pharmaceuticals.

The full article can be found on page 6:  Dec layouts (ptmg.org)